FIRST TRUST ADVISORS LP

Position in NVAX — Novavax Inc

CIK 1125816 Wheaton, IL

Position in NVAX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,633,284

+$301,355 QoQ

Shares Held

385,699

-5.8% QoQ

Ownership

0.234%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 263 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. NVAX ranks #70 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,633,284	385,699	-5.8%	Shares	Sole	2026-08-11
2026-03-31	$3,331,929	409,328	+37.7%	Shares	Sole	2026-05-13
2025-12-31	$1,997,983	297,319	+52.5%	Shares	Sole	2026-02-13
2025-09-30	$1,690,571	194,991	+118.8%	Shares	Sole	2025-11-12
2025-06-30	$561,531	89,132	+14.4%	Shares	Sole	2025-08-13
2025-03-31	$499,217	77,881	-67.7%	Shares	Sole	2025-05-14
2024-12-31	$1,938,580	241,117	-60.5%	Shares	Sole	2025-02-13
2023-03-31	$4,230,259	610,427	+4165.7%	Shares	Sole	2023-05-15
2022-03-31	$1,053,931	14,310	-90.5%	Shares	Sole	2022-05-13
2021-12-31	$21,536,327	150,530	-48.3%	Shares	Sole	2022-02-08
2021-09-30	$60,358,513	291,151	+230.8%	Shares	Sole	2021-11-15
2021-06-30	$18,686,676	88,016	+187.1%	Shares	Sole	2021-10-12
2021-03-31	$5,559,327	30,662	-15.0%	Shares	Sole	2021-05-14
2020-12-31	$4,020,827	36,058	—	Shares	Sole	2021-02-02
No filing history on record for this holder in this stock.